3rd DCT, HYBRID & CENTRALISED CLINICAL TRIALS WORLD CONGRESS 2027 EUROPE
Where Innovation, Collaboration and Human‑Centred Design Meet to Transform Clinical Research
Millennium Hotel and Conference Centre Gloucester London, UK
Day 1 - Thursday 25th February 2027
Strategy, Regulation & Patient‐Centric Transformation
- Integrating decentralised, hybrid and centralised approaches into a cohesive future‐ready ecosystem.
- Regulatory expectations that influence digital trial design, remote data capture, and the operational frameworks required for compliance.
- Patient‐driven priorities that shape protocol flexibility, technology usability, and the overall experience of participating in digitally‐enabled trials.
- Collaboration models that allow pharma, CROs, tech providers and regulators to accelerate modernisation.
Moderator:
Panellists:
- Reviewing evolving guidance on digital consent, telemedicine and remote monitoring.
- Navigating cross‐border compliance challenges in multinational decentralised trials.
- Assessing regulator perspectives on patient‐generated data and digital endpoints.
- Outlining future frameworks that will shape digital trial innovation.
- Determining when decentralisation adds value versus when centralisation is essential.
- Evaluating digital tools across therapeutic areas for measurable operational gains.
- Considering budgeting, ROI and resource allocation for digital transformation.
- Building internal capabilities to support scalable hybrid trial execution.
- Redesigning workflows to support seamless coordination between remote and on‐site activities.
- Staff training frameworks that build confidence in digital tools and ensure consistent execution across sites.
- Addressing multi‐vendor complexity and the operational challenges associated with fragmented technology.
- Maintaining data quality and protocol adherence across decentralised modalities and diverse patient environments.
- Streamlining data flows across eCOA, eConsent, wearables and telemedicine.
- Reducing site burden through automation and integrated workflows.
- Real‐time monitoring tools that enhance operational visibility, enabling proactive issue resolution and improved trial predictability.
- Vendor collaboration models that support scalability, reduce fragmentation and strengthen long‐term digital infrastructure.
- Exploring design principles that ensure digital platforms are intuitive, accessible and inclusive
- Improving adherence through personalised digital engagement.
- Simplifying remote procedures to reduce patient burden enabling high‐quality data capture and safety oversight.
- How patient‐centric digital tools improve recruitment outcomes and broaden access to diverse populations?
- The journey from individual DCT experiences to a nationally shared knowledge resource.
- Building effective public-private collaboration around clinical trial innovation.
- Capturing lessons learned from multiple DCT elements and stakeholders.
- Making DCT implementation easier, faster and more predictable.
- How the Swedish model can be adapted and reused in other countries.
Mats Thoring, Site Management DCT Advisor, Pharmaceuticals Division, Bayer AB
For many people living with chronic health conditions, observation, monitoring, sampling, data collection and analysis
are familiar actions. Their lived expertise can:
- Identify what is practical, preferable, tolerable and acceptable in terms of trial participation
- Identify the impact, burden or disruption of participation to how they live with their condition/s
- Directly inform innovative trial design with potential to improve recruitment and how they would live with participation
- Identify aspects of participation and trial delivery that could be integrated into decentralised, remote or hybrid design
- Provide perspective on consistency and integrity of data capture, safety and monitoring
- Provide foresight early in product development, establishing the logistical considerations associated with formulation, dosing, storage and delivery mechanisms
- Demonstrate how familiarity through chronic health management can influence industry requirements for
innovative trial design
Lorna Allen, Community Engagement and Involvement Lead, Cystic Fibrosis Trust
- Identifying digital literacy gaps across patient communities and strategies to support individuals with limited technology experience.
- Co‐designing protocols with patient groups for more practical, usable and inclusive trial experiences.
- Exploring accessibility considerations for rare disease, mobility‐limited and geographically remote patients.
- Approaches that strengthen trust and empower patients throughout digitally‐enabled participation.
4:30 pm - Harnessing AI‐Enabled Safety Monitoring to Improve Remote Oversight and Patient Protection
- Predictive analytics tools that identify emerging safety signals earlier and support proactive intervention strategies.
- Automated remote assessment workflows to reduce manual burden and improve consistency in safety monitoring.
- Integrating AI outputs into regulatory‐compliant processes without compromising oversight or data integrity.
- Patient‐experience improvements enabled by timely, personalised safety interventions
- How sites balance remote responsibilities with traditional on‐site activities while maintaining operational efficiency.
- Addressing technology overload and presenting strategies for platform consolidation that reduce complexity.
- Digital competency programmes that equip site staff with the skills needed to manage modern trial technologies.
- Best practices for maintaining high‐quality data capture and patient engagement in hybrid environments.
- Combining regulatory evolution, hybrid strategy and patient priorities into a unified direction for digital trials.
- Integrating interoperability, technology consolidation and site readiness to strengthen operational foundations.
- Translating academic evidence and public‐sector initiatives into practical frameworks for scalable decentralised research.
- Building long‐term alignment across sponsors, CROs, tech providers, patients and regulators to support sustainable transformation.
Moderator:
Panellists:
Co-located with the 10th Patient Centricity & Collaboration World Congress 2027 Europe.
Joint Networking & Exhibit Area.
